Alkermes will likely proceed with its planned acquisition of Avadel, which experienced an unexpected hitch following Lundbeck’s counteroffer.

Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.

The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular lymphoma (FL).

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and challenges ahead.

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...

Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more exacerbations in the past year.

At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical trials.

Italvacuum, a leading manufacturer of vacuum pumps and industrial drying systems for the pharmaceutical and fine chemical industries, announced its participation at CPHI | PMEC India 2025, taking ...

Merus and Halozyme have signed a worldwide non-exclusive partnership and licence agreement for subcutaneous formulation of petosemtamab.

Johnson & Johnson has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a deal valued at $3.05bn in cash.

The FDA’s verdict on Poherdy comes amid Perjeta creator Genentech’s patent infringement lawsuit against Organon and Shanghai Henlius Biotech.